Bausch + Lomb Corporation
BLCO.TOTSXHealthcare● Active
$21.64
+$0.39(+1.84%)
Market Cap$7.7B
P/E Ratio—
52W High$25.7
52W Low$15.69
Bausch + Lomb Corporation (BLCO.TO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BLCO.TO · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 29, 2026EPS Actual
$0.11
Est. $0.07 · +57.0%
Revenue
$1.73B
Est. $1.69B · +2.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 29, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
BLCO.TO reports quarterly as a TSX-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 29, 2026 | $0.21 | — | — | — | $1.90B | — |
| ▲ Q2 FY2026 | Apr 29, 2026 | $0.07 | $0.11 | +57.0% | $1.73B | $1.69B | +2.3% |
| ▼ Q1 FY2026 | Feb 18, 2026 | $0.49 | $0.44 | -9.9% | $1.93B | $1.90B | +1.4% |
| ▼ Q4 FY2025 | Oct 29, 2025 | $0.36 | -$0.11 | -130.7% | $1.79B | $1.38B | +29.1% |
| ▼ Q3 FY2025 | Jul 30, 2025 | $0.15 | -$0.24 | -263.6% | $1.74B | $1.28B | +36.4% |
| ▼ Q2 FY2025 | Apr 30, 2025 | $0.09 | -$0.07 | -177.8% | $1.62B | $1.25B | +29.2% |
| ▲ Q1 FY2025 | Feb 19, 2025 | $0.23 | $0.25 | +8.7% | $1.84B | $1.15B | +60.0% |
| ▲ Q4 FY2024 | Oct 30, 2024 | $0.16 | $0.17 | +6.3% | $1.62B | $1.25B | +29.4% |
Q3 FY2026
Jul 29, 2026
EPS Actual
—
EPS Est.
$0.21
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 29, 2026Beat
EPS Actual
$0.11
EPS Est.
$0.07
EPS Surpr.
+57.0%
Revenue
$1.73B
Q1 FY2026
Feb 18, 2026Miss
EPS Actual
$0.44
EPS Est.
$0.49
EPS Surpr.
-9.9%
Revenue
$1.93B
Q4 FY2025
Oct 29, 2025Miss
EPS Actual
-$0.11
EPS Est.
$0.36
EPS Surpr.
-130.7%
Revenue
$1.79B
Q3 FY2025
Jul 30, 2025Miss
EPS Actual
-$0.24
EPS Est.
$0.15
EPS Surpr.
-263.6%
Revenue
$1.74B
Q2 FY2025
Apr 30, 2025Miss
EPS Actual
-$0.07
EPS Est.
$0.09
EPS Surpr.
-177.8%
Revenue
$1.62B
Q1 FY2025
Feb 19, 2025Beat
EPS Actual
$0.25
EPS Est.
$0.23
EPS Surpr.
+8.7%
Revenue
$1.84B
Q4 FY2024
Oct 30, 2024Beat
EPS Actual
$0.17
EPS Est.
$0.16
EPS Surpr.
+6.3%
Revenue
$1.62B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.37 | $0.38 | $0.38 | 5 |
| Q3 FY2027 | $0.26 | $0.26 | $0.27 | 5 |
| Q2 FY2027 | $0.26 | $0.26 | $0.26 | 5 |
| Q1 FY2027 | $0.16 | $0.16 | $0.16 | 5 |
| Q4 FY2026 | $0.35 | $0.36 | $0.36 | 10 |
| Q3 FY2026 | $0.19 | $0.22 | $0.25 | 12 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $1.6B | $1.6B | $1.6B | 6 |
| Q3 FY2027 | $1.4B | $1.4B | $1.5B | 6 |
| Q2 FY2027 | $1.4B | $1.4B | $1.5B | 6 |
| Q1 FY2027 | $1.3B | $1.3B | $1.3B | 6 |
| Q4 FY2026 | $1.5B | $1.5B | $1.5B | 6 |
| Q3 FY2026 | $1.4B | $1.4B | $1.4B | 13 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 29, 2026 | +57.0% | $21.58 | $21.02 | -2.59% |
| ▼ Q1 FY2026 | Feb 18, 2026 | -9.9% | $24.23 | $24.13 | -0.41% |
| ▼ Q4 FY2025 | Oct 29, 2025 | -130.7% | $21.15 | $21.67 | +2.46% |
| ▼ Q3 FY2025 | Jul 30, 2025 | -263.6% | $20.17 | $18.91 | -6.25% |
| ▼ Q2 FY2025 | Apr 30, 2025 | -177.8% | $19.00 | $15.25 | -19.74% |
| ▲ Q1 FY2025 | Feb 19, 2025 | +8.7% | $23.09 | $23.18 | +0.39% |
| ▲ Q4 FY2024 | Oct 30, 2024 | +6.3% | $28.88 | $28.49 | -1.35% |
| ▲ Q3 FY2024 | Jul 31, 2024 | +8.3% | $23.48 | $23.70 | +0.94% |
Q2 FY2026-2.59%
Report Date
Apr 29, 2026
EPS Beat/Miss
+57.0%
Price Before
$21.58
Price After
$21.02
Q1 FY2026-0.41%
Report Date
Feb 18, 2026
EPS Beat/Miss
-9.9%
Price Before
$24.23
Price After
$24.13
Q4 FY2025+2.46%
Report Date
Oct 29, 2025
EPS Beat/Miss
-130.7%
Price Before
$21.15
Price After
$21.67
Q3 FY2025-6.25%
Report Date
Jul 30, 2025
EPS Beat/Miss
-263.6%
Price Before
$20.17
Price After
$18.91
Q2 FY2025-19.74%
Report Date
Apr 30, 2025
EPS Beat/Miss
-177.8%
Price Before
$19.00
Price After
$15.25
Q1 FY2025+0.39%
Report Date
Feb 19, 2025
EPS Beat/Miss
+8.7%
Price Before
$23.09
Price After
$23.18
Q4 FY2024-1.35%
Report Date
Oct 30, 2024
EPS Beat/Miss
+6.3%
Price Before
$28.88
Price After
$28.49
Q3 FY2024+0.94%
Report Date
Jul 31, 2024
EPS Beat/Miss
+8.3%
Price Before
$23.48
Price After
$23.70
Avg Beat Reaction-0.65%
Avg Miss Reaction-5.98%
Beat Rate4 / 8 quarters
Largest Move-19.74% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BLCO.TO ends December
Bausch + Lomb Corporation (BLCO.TO) most recently reported earnings on April 29, 2026 for Q2 FY2026, posting EPS of $0.11 — beating the analyst consensus of $0.07 by +57.0%. The next BLCO.TO earnings date is expected around September 1, 2026.
Each quarter, investors track BLCO.TO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BLCO.TO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BLCO.TO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BLCO.TO earnings · 5 questionsBausch + Lomb Corporation's next earnings report is expected around September 1, 2026. BLCO.TO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BLCO.TO historically reports after market close (AMC).
BLCO.TO earnings datewhen is BLCO.TO earningsBLCO.TO next earnings datewhen does BLCO.TO report earningsBLCO.TO earnings calendar
▸ Source: FMP · Bausch + Lomb Corporation SEC filings · US GAAP · Bausch + Lomb Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026